Clinical Trials List
2025-09-01 - 2031-06-30
Recruiting6
ICD-10C50.011
Malignant neoplasm of nipple and areola, right female breast
ICD-10C50.012
Malignant neoplasm of nipple and areola, left female breast
ICD-10C50.019
Malignant neoplasm of nipple and areola, unspecified female breast
ICD-10Z51.12
Encounter for antineoplastic immunotherapy
ICD-9174.0
Malignant neoplasm of female breast, nipple and areola
-
Trial Applicant
IQVIA RDS Taiwan Ltd.
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/04/01
Investigators and Locations
Co-Principal Investigator
- 林柏翰 Division of General Internal Medicine
- 楊明翰 Division of Hematology & Oncology
- WEI-LI MA Division of Hematology & Oncology
- MING-YANG WANG Division of General Surgery
- 陳怡君 Division of Hematology & Oncology
- 李佳真 Division of Hematology & Oncology
- 羅喬 Division of General Surgery
- Wei-Wu Chen Division of Hematology & Oncology
- 張端瑩 Division of Hematology & Oncology
- 黃柏翔 Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- 陳彥蓁 Division of General Surgery
- Chun-Yu Liu Division of Hematology & Oncology
- 林燕淑 Division of General Surgery
- 邱仁輝 Division of General Surgery
- Jiun-I Lai Division of Hematology & Oncology
- Ta-Chung Chao Division of Hematology & Oncology
- 賴亦貞 Division of Radiology
- 鄭涵方 Division of General Surgery
- Yi-Fang Tsai Division of General Surgery
- Chi-Cheng Huang Division of General Surgery
- 馮晉榮 Division of General Surgery
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- 楊捷儒 Division of General Surgery
- I-Chen Tsai Division of General Surgery
- 林慈恩 Division of General Surgery
- Kuan-Der Lee Division of Hematology & Oncology
- Huey-En Tzeng Division of Hematology & Oncology
- 王國鐘 Division of General Surgery
- 楊陽生 Division of Hematology & Oncology
- ZHENG-WEI ZHOU Division of Hematology & Oncology
- 劉佳樺 Division of General Surgery
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Wen-Chi Shen Division of Hematology & Oncology
- Mengting Peng Division of Hematology & Oncology
- 阮昱翔 Division of Hematology & Oncology
- Shin-Cheh Chen Division of General Surgery
- 周旭桓 Division of General Surgery
- Chi-Chang Yu Division of General Surgery
- 陳怡文 Division of Endocrinology
- Wen-Ling Kuo Division of General Surgery
- Chan-Keng Yang Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- 林昶廷 Division of Hematology & Oncology
- 陳彥豪 Division of Hematology & Oncology
- Tai-Jan Chiu Division of Hematology & Oncology
- 陳彥仰 Division of Hematology & Oncology
- 郭明濬 Division of Hematology & Oncology
- Yu-Li Su Division of Hematology & Oncology
- Shau-Hsuan Li Division of Hematology & Oncology
- 蔡宗翰 Division of Hematology & Oncology
- 李易濰 Division of Radiology
- 吳佳哲 Division of Hematology & Oncology
- 黃詩喻 Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- 廖立民 Division of General Surgery
- KA-WAI TAM Division of General Surgery
- Yao-Yu Hsieh Division of Hematology & Oncology
- 莊博雅 Division of Hematology & Oncology
- Wei-Hong Cheng Division of Hematology & Oncology
- HUI-WEN LIU Division of Hematology & Oncology
- 蔡承志 Division of Hematology & Oncology
- 蘇智銘 Division of General Surgery
The Actual Total Number of Participants Enrolled
0 Recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
10 participants
-
Global
540 participants
